Because of Accelerate NC, Tina, Damon, and many others enjoy higher-than-average wages in a career with upward mobility, and ...

Durham-based Humacyte, founded by three female scientists in 2004, has received marketing approval from the U.S. Food and ...

NCBiotech is working with statewide partners to drive strategy and support the CRO sector. By working together to expand the clinical-based workforce and awareness of the CRO community, North Carolina ...

Raleigh sustainable food startup Atlantic Fish Co has developed and tested a cultivated black sea bass prototype, the company’s latest milestone in the production of sustainable seafood made from ...

A Morrisville-based biopharmaceutical company has received special regulatory status for a potential new treatment for acute pancreatitis. Arrivo BioVentures said the U.S. Food and Drug Administration ...

In modern medicine, however, medical devices and diagnostics are continuously evolving. So they may stand completely independent of one another. There are companies in North Carolina creating ...

Grifols, a global manufacturer of plasma-based medicines headquartered in Barcelona, Spain, held a celebration to mark 50 years in Clayton, NC. Grifols acquired the Johnston County facility in 2011 ...

Bioventus, a global orthobiologics company based in Durham, has launched Durolane, its single-injection, hyaluronic acid (HA) joint lubricant for treating knee osteoarthritis pain, following FDA ...

In September 2022, NCBiotech and our coalition of partners received a $25 million Phase 2 award from the U.S. Economic Development Administration’s Build Back Better Regional Challenge *. This award ...

Patients who have hereditary angioedema, or HAE, can experience sudden and rapid swelling, often in the feet, hands, and abdomen. These unexpected attacks can also close off airways, potentially ...

An initiative connecting military talent with job opportunities in North Carolina’s growing biopharmaceutical manufacturing industry will expand, thanks to a new federal grant. The two-year, $825,000 ...